(Q48438119)

11 February 2018

title

Safety pharmacology, toxicology and pharmacokinetic assessment of recombinant human omega-interferon produced from CHO-SS cells (English)

1 reference

11 February 2018

1 reference

1 reference

Victor E Buckwold

1

1 reference

11 February 2018

William Lang

2

1 reference

11 February 2018

Curtis Scribner

3

1 reference

11 February 2018

Dennis Blanchett

4

1 reference

11 February 2018

Tom Alessi

5

1 reference

11 February 2018

Peter Langecker

6

1 reference

11 February 2018

publication date

1 July 2006

1 reference

11 February 2018

Basic and Clinical Pharmacology and Toxicology

published in

1 reference

11 February 2018

volume

99

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

62-70

1 reference

11 February 2018

Human interferon ω1: isolation of the gene, expression in Chinese hamster ovary cells and characterization of the recombinant protein

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

Immunogenicity of interferon beta: differences among products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

Side effects of alpha interferon in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

Revised methods for the Salmonella mutagenicity test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

Hepatitis C treatment update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

21 January 2018

The micronucleus test

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_365.X

10.1111/J.1742-7843.2006.PTO_365.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018